Trials / Completed
CompletedNCT03319693
Molecular Characterization of Primary Mucosal Melanoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 65 (actual)
- Sponsor
- CHU de Reims · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Primary mucosal melanomas (MPM) are rarer than cutaneous melanomas, but also more severe. They are usually refractory to conventional approaches, regularly excluded from major therapeutic programs and not sensitive to new targeted therapies orphans. " The identification of therapeutic targets and accessibility to existing, developing or future targeted therapies improves the survival of patients with MPM. The principal goal is to describe, using a large panel of genes, the prevalence of major mutations in a cohort of MPMs based on the population of a French region.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | Somatic Genetic | NGS analysis |
Timeline
- Start date
- 2017-08-28
- Primary completion
- 2019-04-28
- Completion
- 2021-04-28
- First posted
- 2017-10-24
- Last updated
- 2024-08-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03319693. Inclusion in this directory is not an endorsement.